Normal view MARC view ISBD view

The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor : predicting and looking at the possible case scenarios

In European Journal of Nuclear Medicine and Molecular Imaging
By: Basu S.
Contributor(s): Ostwal V.
Material type: materialTypeLabelArticleSeries: Vol. 43 ,no. 13.Publisher: Berlin Springer-Verlag Berlin 2016Description: 2453-2455.Subject(s): peptide receptor radionuclide therapy | neuroendocrine tumor | FDG-PET/CT | Chemotherapy | 177Lu-DOTATATE | 68Ga-DOTATATEOnline resources: Click here to access online In: European Journal of Nuclear Medicine and Molecular Imaging Vol.43, no.13, p.2453-2455
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
Available AR17746

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha